FDA Approves Mavyret, a Pan-Genotypic Treatment for HCV

Fred Poordad

Transplant Center

Press/Media: Press / Media

Period	Aug 1 2017 → Aug 3 2017

Media coverage

2

Media coverage

Title FDA Approves Mavyret, a Pan-Genotypic Treatment for HCV
Media name/outlet Monthly Prescribing Reference
Country United States
Date 8/3/17
Persons Fred Poordad
Title FDA Approves Mavyret, a Pan-Genotypic Treatment for HCV
Media name/outlet Monthly Prescribing Reference (MPR)
Country United States
Date 8/1/17
Persons Fred Poordad